ERIS Lifesciences Ltd share price logo

ERIS Lifesciences Ltd

NSE: ERIS

BSE: 540596

Small Cap

Pharma Sector

₹1310.10

-45.40

(-3.35%)

as on

bell
The current prices are delayed by 15 mins, login to check live prices.

Tech Chart

What are INDmoney investors doing with ERIS Lifesciences shares?

Based on platform-user behaviour - not analyst opinion or company fundamentals.

Search interest on INDmoney

-6%

Searches for ERIS Lifesciences on INDmoney have decreased by 6% over the last 30 days.

Average holding period of indmoney investors

29 days

INDmoney investors hold ERIS Lifesciences shares for an average of 29 days.

Key Events for ERIS Lifesciences

Last Dividend Declared

₹7.21 per share, declared on 20/05/2026

View Dividend History

ERIS Lifesciences Stock Performance

as on September 15, 2026 at 9:31 pm IST

  • Day's Low

    Day's High

    ₹1,300.60
    ₹1,359.90
    downward going graph

    0.73%

    Downside

    3.80%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    ₹1,200.00
    ₹1,745.00
    downward going graph

    8.40%

    Downside

    33.20%

    Upside

    downward going graph

ERIS Lifesciences share price movements today

Previous Close
₹1,355.50
Open
₹1,355.50
Volume
44.18K
Upper Circuit
₹1,626.60
Lower Circuit
₹1,084.40
Day's Low - High
₹1,300.60 - ₹1,359.90
52 Week Low - High
₹1,200.00 - ₹1,745.00

ERIS Lifesciences Historical Returns

1 Month Return
+ 0.49 %
3 Month Return
-2.09 %
1 Year Return
-19.02 %
3 Year Return
+ 64.96 %
5 Year Return
+ 79.26 %

ERIS Lifesciences Fundamentals

as on September 15, 2026 at 4:01 pm IST

Market Cap

₹18,784.97 Cr

Return on Equity (ROE)

8.55

PE Ratio (TTM)

28.83

Return on capital employed (ROCE)

10.66

Industry PE ratio

51.81

Beta (LTM)

0.56

P/B Ratio

5.63

Dividend Yield

0.56

PEG Ratio

1.55

Quarterly Earnings Growth YOY

14.56

EPS (TTM)

46.75

Book Value

281.78

ERIS Lifesciences Stock Valuation

as on September 15, 2026 at 4:01 pm IST

ERIS Lifesciences in the last 5 years

  • Overview

  • Trends

Lowest (16.77x)

September 9, 2019

Today (28.83x)

September 11, 2026

Industry (51.81x)

September 11, 2026

Highest (71.34x)

June 16, 2025

LowHigh

Today’s Price to Earnings Ratio: 28.83x

ERIS Lifesciences Technical Analysis

Track how ERIS Lifesciences technical analysis has moved over time to understand its trends.

1 min
5 min
15 min
30 min
1 day
1 week
1 month

Technicals Summary

Bearish

Neutral

Bullish

Bearish

Moving Averages

Bearish

Neutral

Bullish

Bearish

Oscillators

Bearish

Neutral

Bullish

Bearish

Overall

Bearish10
Bullish4
Neutral1

Oscillators

Name

Value

Action

MACD level (12,26)
-1.34
Bullish
CCI (20)
498.96
Bearish
RSI (14)
45.51
Neutral
Momentum (10)
0.8
Bullish
ADI (14)
51.26
Bearish
Ultimate Oscillator (7,14,28)
22.01
Bearish

Moving Averages

Name

Value

Action

SMA (20)
1309.76
Bullish
EMA (20)
1310.01
Bearish
VWMA (20)
1309.31
Bullish
SMA (50)
1313.95
Bearish
EMA (50)
1314.02
Bearish
SMA (200)
1334.43
Bearish
EMA (200)
1330.02
Bearish
KAMA (200)
1310.24
Bearish
DEMA (200)
1315.77
Bearish

ERIS Lifesciences Ltd vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of ERIS Lifesciences with its industry peers.

Company
Analyst View
Market Cap(in ₹ Cr)
5 Year CAGRDebt to Asset Ratio
Net Profit(in ₹ Cr)
Yearly Revenue(in ₹ Cr)
ERIS Lifesciences Ltd image
ERIS Lifesciences Ltd
BUY18,784.9715.85%0.696473,129
Beryl Drugs Ltd image
Beryl Drugs Ltd
NA12.1721.22%0.00-121
Astrazeneca Pharma India Ltd image
Astrazeneca Pharma India Ltd
NA16,911.2523.08%0.001872,275
Kilitch Drugs (India) Ltd image
Kilitch Drugs (India) Ltd
NA650.180.17%0.6229235
Ambalal Sarabhai Enterprises Ltd image
Ambalal Sarabhai Enterprises Ltd
NA309.067.3%0.6317202
See all

Market expectation of ERIS Lifesciences Stock

Common consensus of the market based on various publicly available news, publications,brokerage expectation and market data

BUY

90.91%

Buy

9.09%

Hold

0.00%

Sell

ERIS Lifesciences Ltd Quarterly Profit & Loss

Figures in Rupees Crores

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Sales
500.52
483.48
547.27
715.59
738.95
722.12
702.6
771.56
790.15
800.89
752.29
869.03
Other Income
3.48
4.2
15.15
1.64
4.55
4.22
8.01
3.58
3.09
0.14
2.23
2.39
Total Income
508.78
490.5
566.08
721.36
745.72
731.67
713.31
776.58
795.5
807.59
758.79
875.64
Expenses
324.16
310.79
402.5
469.73
476.66
477.14
452.91
496.29
504.2
543.08
484.19
577.43
Operating Profit
176.36
172.69
144.77
245.86
262.29
244.98
249.69
275.27
285.95
257.81
268.1
291.6
Operating Profit Margin %
35.24%
35.72%
26.45%
34.36%
35.49%
33.93%
35.54%
35.68%
36.19%
32.19%
35.64%
33.55%
Profit Before Interest, Tax and Depreciation
184.63
179.71
163.58
251.63
269.06
254.53
260.4
280.29
291.3
264.51
274.6
298.21
Interest
16.3
18.12
33.03
60.37
59.47
57.17
54.28
48.68
49.55
48.82
45.62
46.65
Depreciation
42.09
45.72
53.8
75.74
80.48
81
77.25
70.51
69.08
70.34
69.57
72.07
Profit Before Tax
126.24
115.87
76.75
115.52
129.11
116.36
128.87
161.1
172.67
145.35
159.41
179.49
Tax Paid
3.93
14.41
-2.95
25.97
32.76
29.3
26.52
36
38.2
36.52
-119.69
36.17
Profit After Tax
122.31
101.46
79.7
89.55
96.35
87.06
102.35
125.1
134.47
108.83
279.1
143.32
Total Net profit including share of profit / Loss from associate company
122.31
101.46
79.7
89.55
96.35
87.06
102.35
125.1
134.47
108.83
279.1
143.32
EPS
9.08
7.55
5.22
6.11
6.73
6.16
6.9
8.66
8.82
7.32
20.6
10.28
Actual EPS
9.08
7.55
5.22
6.11
6.73
6.16
6.9
8.66
8.82
7.32
20.6
10.28
Adjusted EPS
9.08
7.55
5.22
6.11
6.73
6.16
6.9
8.66
8.82
7.32
20.6
10.28
Diluted EPS
9.06
7.54
5.21
6.1
6.72
6.15
6.89
8.64
8.81
7.31
20.57
10.26

ERIS Lifesciences Ltd Annual Profit & Loss

Figures in Rupees Crores

Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Mar 2026
Sales
827.1
967.2
1,058.18
1,192.64
1,326.17
1,661.82
1,991.3
2,879.26
3,114.89
Other Income
26.41
31.69
15.4
8.71
26.09
11.15
23.82
18.42
7.84
Total Income
882.01
1,013.86
1,089.46
1,220.57
1,373.14
1,696.3
2,032.97
2,912.06
3,137.26
Expenses
533.59
637.25
705.69
781.29
862.09
1,148.4
1,334.32
1,876.44
2,026.55
Operating Profit
293.51
329.95
352.49
411.35
464.08
513.42
656.98
1,002.82
1,088.34
Operating Profit Margin %
35.49%
34.11%
33.31%
34.49%
34.99%
30.9%
32.99%
34.83%
34.94%
Profit Before Interest, Tax and Depreciation
348.42
376.61
383.77
439.28
511.05
547.9
698.65
1,035.62
1,110.71
Interest
10.55
22.9
2.16
1.8
4.15
26.17
84.8
231.29
192.67
Depreciation
25.64
36.35
50.26
42.99
64.71
117.09
182.51
315.46
279.5
Profit Before Tax
312.23
317.36
331.35
394.49
442.19
404.64
431.34
488.87
638.54
Tax Paid
17.25
26.21
34.85
39.36
36.4
30.48
34.22
114.2
-8.97
Profit After Tax
294.98
291.15
296.51
355.14
405.79
374.16
397.12
374.67
647.51
Total Net profit including share of profit / Loss from associate company
294.98
291.15
296.51
355.14
405.79
374.16
397.12
374.67
647.51
EPS
21.39
21.15
21.61
26.16
29.89
28.1
28.82
25.85
45.33
Actual EPS
21.39
21.15
21.61
26.16
29.89
28.1
28.82
25.85
45.33
Adjusted EPS
21.39
21.15
21.61
26.16
29.89
28.1
28.82
25.85
45.33
Diluted EPS
21.39
21.13
21.59
26.14
29.88
28.07
28.79
25.81
45.26

ERIS Lifesciences Ltd Cash Flow

Figures in Rupees Crores

Mar 2016
Mar 2017
Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Mar 2026
Net Cash from Operating Activities
131.48
200.21
234.64
223
271.17
375.36
378.26
291.74
486.01
1,065.01
537.99
Cash Flow from Investing Activities
-43.91
-184.45
-590.1
-12.7
123.23
-323.36
-319.6
-974.61
-1,827.66
-78.2
-369.46
Cash Flow from Financing Activities
-83.7
-23.66
363.21
-221.05
-334.6
-82.4
-45.15
688.04
1,379.78
-881.32
-313.53
Net Cash Flow
3.87
-7.91
7.75
-3.11
59.81
-30.39
13.96
5.15
38.13
105.49
-145

ERIS Lifesciences Stock Shareholding Pattern

Numbers in percentages

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Promoters
54.9%
54.9%
54.88%
54.87%
54.86%
54.85%
54.84%
54.85%
54.85%
53.92%
54.14%
DII
13.86%
15.63%
16.23%
18.64%
18.06%
18.07%
18.17%
19.36%
20.32%
20.35%
20.72%
FII
0%
14.27%
14.59%
8.01%
8.35%
8.43%
8.4%
7.21%
6.85%
6.39%
5.75%
Public
17.41%
15.19%
14.3%
18.47%
18.72%
18.66%
18.59%
18.57%
17.99%
19.33%
19.4%
Total Outstanding Shares
13,60,28,280
13,60,28,280
13,60,75,008
13,61,05,792
13,61,29,282
13,61,62,569
13,61,97,325
13,62,13,554
13,62,16,891
13,85,42,887
13,85,78,489
Total Shareholders
46,496
51,753
44,176
46,346
53,314
50,087
52,225
59,438
54,713
51,656
50,798

ERIS Lifesciences Corporate Actions

View detailed summary of the earnings and dividend history of ERIS Lifesciences.

  • ERIS Lifesciences Ltd Earnings Results

    ERIS Lifesciences Ltd’s net profit jumped 20.68% since last year same period to ₹142.39Cr in the Q1 2026-2027. On a quarterly growth basis, ERIS Lifesciences Ltd has generated -49.44% fall in its net profits since last 3-months.

    Read More about Earnings Results

  • ERIS Lifesciences Ltd Dividends May,2026

    In the quarter ending March 2026, ERIS Lifesciences Ltd has declared dividend of ₹7.21 per share on 20 May 2026 - translating a dividend yield of 0.53%.

    Read More about Dividends

Indices Featuring ERIS Lifesciences Stock

Check stock indices that include ERIS Lifesciences.

Nifty Smallcap 250

₹17,892.80

-447.10 (▲2.44%)

BSE Healthcare

₹50,478.81

-759.32 (▲1.48%)

BSE 500

₹35,169.62

-603.62 (▲1.69%)

Nifty 500

₹22,477.45

-389.05 (▲1.70%)

S&P BSE 400 MidSmallCap

₹12,406.84

-285.09 (▲2.25%)

S&P BSE 250 SmallCap

₹7,052.62

-173.07 (▲2.40%)

Nifty MidSmallcap 400

₹20,750.70

-476.25 (▲2.24%)

Insights on ERIS Lifesciences Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Promoter Holding Up

    img

    Promoters have increased holdings from 53.92% to 54.14% in Jun 2026 quarter

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 7 days, ERIS stock has moved up by 2.3%

  • imgPOSITIVE IMPACT

    Retail Holding Up

    img

    Retail Investor have increased holdings from 19.33% to 19.40% in Jun 2026 quarter

  • imgPOSITIVE IMPACT

    MF Holding Up

    img

    Mutual Funds have increased holdings from 18.22% to 18.88% in Jun 2026 quarter

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 2 quarters, 758.79 Cr → 875.64 Cr (in ₹), with an average increase of 13.3% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Torrent Pharmaceuticals Ltd has given 165.3% return, outperforming this stock by 100.3%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Divis Laboratories Ltd has given 53.9% return, outperforming this stock by 72.9%

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 2 quarters, 281.61 Cr → 142.39 Cr (in ₹), with an average decrease of 49.4% per quarter

  • imgNEGATIVE IMPACT

    FII Holding Down

    img

    Foreign Institutions have decreased holdings from 6.39% to 5.75% in Jun 2026 quarter

About ERIS Lifesciences Ltd

Eris Lifesciences Limited was incorporated in 2007 and is engaged in manufacturing, distributing and marketing of branded pharmaceutical products, having presence in high growth chronic, sub-chronic and acute therapeutic areas. It has a portfolio of 112 Mother Brands across therapy areas and 5 subsidiaries, 4 of which are wholly owned subsidiaries. The company has made two acquisitions - UTH Healthcare Ltd for Rs 129 million for its product portfolio in 2017 and Indian branded formulations business Strides for Rs 5000 crore in 2017. It made its debut in secondary equity market in 2017 and in FY 2018 capital expenditure amounted to Rs 242.69 million and Rs 5061.52 million was paid towards business acquisition. In FY 2019 the company expanded its operations by constructing new softgel facility, extended facility for supplements and nutraceuticals, and added Zomelis products in its portfolio. In 2020, Kinedex became wholly owned subsidiary and the company launched new business divisions. In FY21 it launched Gluxit in SGLT2 segment, Eritel and LNBloc maintained ranks in their respective segments, developed Bricet and fortified portfolio with the launch of ZACD. In FY22 it acquired 100 stake in Oaknet Healthcare Ltd worth Rs 6500 million and launched human insulin through its subsidiary Eris M.J. Biopharm Ltd and Xsulin in vials and cartridges.

Revenue: ₹869.03Cr as on June 2026 (Q1 FY27)
Net Profit: ₹143.32Cr as on June 2026 (Q1 FY27)
Listing date: 29 Jun, 2017
Chairperson Name: Amit Indubhushan Bakshi
OrganisationERIS Lifesciences Ltd
HeadquartersAhmedabad
IndustryPharmaceuticals
CEOAmit Indubhushan Bakshi
E-voting on sharesClick here to vote

FAQs

What is ERIS Lifesciences share price today?

ERIS Lifesciences share price today stands at ₹1310.1 as on at the close of the market. ERIS Lifesciences share today touched a day high of ₹1359.9 and a low of ₹1300.6.

What is the 52 week high and 52 week low range for ERIS Lifesciences share?

ERIS Lifesciences touched a 52 week high of ₹1745 and a 52 week low of ₹1200. ERIS Lifesciences share price today i.e. is closed at ₹1310.1, which is -24.92% down from its 52 week high and 9.17% up from its 52 week low.

What is ERIS Lifesciences's market capitalisation today?

ERIS Lifesciences market capitalisation is ₹18,784.97 Cr as on .

How to buy ERIS Lifesciences shares?

To buy ERIS Lifesciences shares, you need to follow these steps:

  • Open a Demat account and Trading account on INDmoney
  • Fund your Trading account
  • Search for ERIS or ERIS Lifesciences Ltd on the INDmoney app to check live prices of the stock
  • Click on Buy or SIP to place an order to invest in ERIS Lifesciences shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

What is ERIS Lifesciences trading volume today?

ERIS Lifesciences trading volume is 44.18K as on . This means that 44.18K shares of ERIS Lifesciences were bought and sold on the stock market during today's trading session.